NEWS

We at ARENSIA are proud to announce today that we have entered into an agreement with Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN) to begin a clinical trial program to test Diffusion’s lead drug trans sodium crocetinate (TSC) for the treatment...

On International Clinical Trials Day we congratulate all patients, all medical professionals and all employees involved in clinical research! Few times in history, if ever, has mankind looked at medicine with more hope and expectations for its inn...

They are the heart of timely data collection with the efficiency of a Swiss Clock, no matter the complexity for sample collection or processing they always make it effortlessly perfect. They are never deterred from the daily activities of coordinatin...

We are eager to bring in all our expertise and clinical research infrastructure to contribute to Phase I, II and III clinical research trials in COVID-19 patients, covering the full range of disease severity. One of ARENSIA´s Phase I researc...

Our world changes daily in fascinating, unpredictable, positive or even dangerous ways, but it is always challenging. The COVID 19 pandemic will definitely change the way we approach health, safety and economic fragility for many years to come. By su...

KEEP CALM BUT KEEP MOVING: The COVID-19 pandemic is rapidly evolving worldwide with major impacts on social life, healthcare systems and the economy. Clinical Research is confronted with a series of unprecedented challenges which must be solved&nb...

Dear Partners, Thank you for the continued trust and support! Our commitment and responsibility towards our patients, employees and partners have never been stronger as we face the COVID-19 pandemic. We are continuously monitoring the “m...

ARENSIA has integrated pharmacies located within each of their Research Clinics. The pharmacies have been commissioned exclusively for the preparation, storage and dispensing of investigational medicinal products (IMP) for clinical trials in complian...

In a world where every variable matters we introduce the concept of Controlled Environment. In research, where even one bit of information could potentially change the outcome, we know exactly how to keep all flows of information, coming IN or OUT, u...

Dear Friends!   Happy New Year to You and Your loved ones from the over 200 members of ARENSIA family around the globe: Germany, Georgia, Lithuania, Moldova, Romania, UK, Ukraine and the US!    2020 is a very special year for us. I...

Dear Colleagues, Partners and Collaborators, It has been a tremendous 1st half of 2019 with some really exciting developments at ARENSIA.   Our continued dedication to complex early phase Ib/IIa studies has amounted to over 50 trials...

With great pleasure ARENSIA is the main corporate partner supporting the first edition of the CLINICAL TRIALS SYMPOSIUM in Romania under the patronage of the European CRO Federation and Romanian Association of CROs. As the industry expands with an...

Düsseldorf, Germany, 25th June, 2019 German based ARENSIA EXPLORATORY MEDICINE GmbH, a clinical research organization specialized to perform Phase Ib/IIa/PROOF OF CONCEPT clinical trials involving patients, announced today its Phase I clinica...

Every year ARENSIA in a partnership with Proventa International organizes a range of events in the USA and Europe, with one goal - to share experiences about Early Clinical Trials.  Industry leaders gather for one-day round table discussions ...

As result of an exceptional start and achievements of our current dedicated clinical research unit in Ukraine, we are extremely excited to inform you that ARENSIA is expanding by opening a 2nd clinical research unit located in the downtown area of Ki...

Dear Health Care Professionals, Dear Colleagues, With great pleasure ARENSIA Exploratory Medicine invites you to attend our annual ICH-GCP training* session on 30th/31st of May 2019 at INTERCONTINENTAL HOTEL in Bucharest, Romania. Good Clinic...

ARENSIA EXPLORATORY MEDICINE GmbH, a German based clinical research organization specialized to perform Phase Ib/IIa/PROOF OF CONCEPT clinical trials involving patients, announced today, that its Phase I clinical research unit in Chisinau, Moldo...

We are pleased to announce ARENSIA Innovative Spotlight Session "Practical Insights and Future Visions to maximize Efficiency in Proof-Of-Concept Patient Trials", which will take place on November 5th, 2018 in Boston, MA. In today's ...

After last year´s success, we take pleasure to inform you that ARENSIA is organizing the 2nd Workshop focused on “Practical Insights and future visions to maximize efficiency in PROOF OF CONCEPT patient trials”. Industry leaders ...

We are pleased to announce ARENSIA Innovative Spotlight Session "Practical Insights and Future Visions to maximize Efficiency in Proof-Of-Concept Patient Trials", which will take place on 16th May 2018 in San Francisco, CA. In today'...

We are pleased to announce ARENSIA Spotlight Session "Innovative Strategies to Achieve First Efficacy Data / Proof-of-Concept in Record Time", which will take place on 7th November 2017 in Boston, MA. In today's fast-changing world, ...

As consequence of the increasing demand for ARENSIA´s capabilities as a specialist for early clinical trials in patients, as of August 2017, ARENSIA expands its operations with a new clinical research unit in Kiev, Ukraine. Ukraine (45 Mio. ...

We are pleased to announce ARENSIA Spotlight Session "Innovative Strategies to Achieve First Efficacy Data / Proof-of-Concept in Record Time", which will take place on 24th May 2017 in San Francisco, CA. In today's fast-changing worl...

At ARENSIA, we are looking back on a very good business year, in which we were able to outdo ourselves with regard to outstanding patient enrolment rates in complex Phase 1, 2a, POC studies at our Phase 1 units in Eastern Europe. Studies involved sop...

As of August 2015, ARENSIA expands its operations with a new clinical research unit in Bucharest, Romania. This unit is fully dedicated to exploratory clinical trials Phase 1 and 2 in PEDIATRIC patients (age 0-18) with chronic and acute conditions...